Sign in

James Snyder

Vice President and Equity Research Analyst at Goldman Sachs Group Inc.

James Snyder is a Vice President and Equity Research Analyst at Goldman Sachs, specializing in the coverage of industrials and transportation companies, including names such as Union Pacific, CSX, and Norfolk Southern. Known for his rigorous financial modeling and timely market insights, Snyder has earned recognition for delivering high-conviction calls that have resulted in notable alpha generation and sector outperformance, with recent reports cited by Bloomberg and Institutional Investor for accuracy and market impact. He began his career at Barclays in 2013 before joining Goldman Sachs in 2017, rising to his current role through a consistent track record of research-driven investment recommendations. Snyder holds FINRA Series 7, 63, 86, and 87 licenses, and has been acknowledged in industry publications for his analytical expertise and client service.

James Snyder's questions to TEXAS INSTRUMENTS (TXN) leadership

Question · Q3 2025

James Snyder asked for insights into the conditions in China, specifically if there was a reversion in orders or if they performed better than expected, and the real-time outlook for Q4. He also questioned if the slower recovery would lead to CapEx for next year being at the lower end of the previously outlined range.

Answer

CEO Haviv Ilan and Head of Investor Relations Mike Beckman reported that China returned to normal in Q3 and is expected to continue into Q4, with industrial in China not showing sequential growth, suggesting no repeat of Q2's pull-forward. Mr. Ilan indicated that while the CapEx framework is $20-$26B, the lower end is more probable given the moderate recovery, emphasizing readiness for any scenario and providing more color in Q1.

Ask follow-up questions

Question · Q3 2025

James Snyder asked for insights into the China business, specifically whether the 'pulling activity' observed last quarter reverted or if orders were better than expected, and real-time trends into Q4 2025. He also inquired about the CapEx outlook for 2026, asking if it would be towards the lower end of the previously outlined range given the slower recovery.

Answer

CEO Haviv Ilan and Head of Investor Relations Mike Beckman stated that China returned to normal in Q3 and is expected to continue into Q4, with no evidence of the Q2 pull-forward repeating. CEO Haviv Ilan confirmed that the probability of 2026 CapEx being lower than the $26 billion upper end of the framework is higher, depending on the recovery pace, with more details to follow in Q1 2026.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts